杭州杰毅生物技术有限公司 https://www.matridx.com 病原分子诊断技术创新引领者 Wed, 01 Apr 2026 09:21:22 +0000 zh-Hans hourly 1 乘势跃马，共拓新局 | 杰毅生物 7 周年庆典隆重举办 https://www.matridx.com/archives/2380 Wed, 01 Apr 2026 09:21:22 +0000 https://www.matridx.com/?p=2380 尼帕病毒精准防控：NGS 技术筑牢感染防线 https://www.matridx.com/archives/2374 Fri, 30 Jan 2026 09:49:20 +0000 https://www.matridx.com/?p=2374 权威认证+1 | 杰毅生物高分通过 tNGS 室间质评 https://www.matridx.com/archives/2364 Fri, 30 Jan 2026 09:03:43 +0000 https://www.matridx.com/?p=2364 实力认证！杰毅生物全面通过下呼吸道、血液、中枢神经系统感染 mNGS 室间质评 https://www.matridx.com/archives/2346 Fri, 26 Dec 2025 05:04:19 +0000 https://www.matridx.com/?p=2346 流感样病例数创近四年新高，混合感染风险激增 https://www.matridx.com/archives/2329 Wed, 17 Dec 2025 06:04:55 +0000 https://www.matridx.com/?p=2329 首批浙江省科技新小龙，杰毅生物光荣入选！ https://www.matridx.com/archives/2320 Wed, 03 Dec 2025 03:35:09 +0000 https://www.matridx.com/?p=2320 标准之上，精准可及：毅达 Lab 全流程方案助推 NGS 检测规范化落地 https://www.matridx.com/archives/2313 Fri, 28 Nov 2025 03:01:39 +0000 https://www.matridx.com/?p=2313 突破 FUO 诊疗困境，杰毅 Onco-mNGS 肿瘤提示科研文章合集（二） https://www.matridx.com/archives/2301 Fri, 14 Nov 2025 02:37:07 +0000 https://www.matridx.com/?p=2301 呼吸道合胞病毒与流感双重威胁，重点人群如何应对感染风险？ https://www.matridx.com/archives/2283 Wed, 12 Nov 2025 06:31:25 +0000 https://www.matridx.com/?p=2283